A Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive

计划入组 213 人 · 首次发布于 2024 年 7 月 29 日

Desmoteplase in Acute Ischemic Stroke (DIAS)

计划入组 104 人 · 首次发布于 2008 年 3 月 19 日

Fecal Microbiota Transplantation for C Diff Infection

计划入组 100 人 · 首次发布于 2013 年 7 月 23 日

DIMS-9078

DIMS-9020

DIMS-9069

DIFA COOPER SPA

Italy

Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke (DIFE)

Germany

KOZMO KIMYA SANAYI VE DIS TICARET LIMITED SIRKETI CORLU SUBESI

Turkey

Nexalin Secures USPTO Patent Allowance for Novel Non-Invasive Addiction Treatment Technology

Nexalin's Neurostimulation Device Shows Significant Cognitive Improvements in Alzheimer's Disease Trial

Nexalin Technology Appoints Carolyn Shelton as SVP of Clinical, Quality & Regulatory Affairs